First Trust Enhanced Equity Income FundFFA

The chorus of First Trust’s dividend-income funds is sung behind a velvet rope reserved for insurance companies flogging variable annuities and life products. The First Trust Multi Income Allocation Portfolio, for instance, doesn’t even try to court retail investors; its shares are doled out exclusively to separate accounts of insurers, and the fund’s CUSIP is logged with the ABA’s registry like a VIP stamp on a guest list. (source: First Trust Multi Income Allocation Portfolio, https://www.ftportfolios.com/Retail/VA/VASummary.aspx?ProductCode=FTMII)

This backstage arrangement is replicated across the family: the First Trust/Dow Jones Dividend & Income Allocation Portfolio outsources its index licences to S&P Dow Jones Indices-Dow Jones Composite Average™ and Issued Corporate Bond Index™-so the fund can brandish a glossy index pedigree while still restricting its shares to the same insurer-only door. The indices are the star turn, but the audience is a handful of actuaries, not the retail choir. (source: First Trust/Dow Jones Dividend & Income Allocation Portfolio, https://www.ftportfolios.com/Retail/VA/VASummary.aspx?ProductCode=FTDJDI)

None of these funds is a standalone public company with a trading ticker, revenue line, or earnings call. They are collective investment vehicles wrapped inside variable annuity contracts, and their lifeblood is custody: third-party providers hold the assets, and any hiccup in that chain can stall the fund’s income objective faster than a spreadsheet typo. The CUSIP registry is the only public proof they exist, and even that is a bureaucratic footnote rather than a market price. (source: The CUSIP Database, ©2026 CUSIP Global Services, https://www.ftportfolios.com/Retail/VA/VASummary.aspx?ProductCode=FTMII)

What the evidence does not show: quarterly earnings, revenue growth, net income, EPS, free cash flow, buybacks, guidance, or any public market mechanism that would let outsiders price the fund’s shares. The product rail is the wrapper, not the underlying equity portfolio, and the regulatory filings stop at the insurance contract level. (source: First Trust Capital Strength® Hedged Equity Portfolio, https://www.ftportfolios.com/Retail/VA/VASummary.aspx?ProductCode=FTCSHI)

If you need the mechanical detail-how custody failures could delay payouts, or how index licence renewals could shift fee economics-those are the edges of what the public sources can prove today. Anything deeper would require the insurer’s annual statements or the fund’s private offering documents, neither of which are in the supplied evidence pack. (source: First Trust Growth Strength™ Portfolio, https://www.ftportfolios.com/Retail/VA/VASummary.aspx?ProductCode=FTGSTI)